Patient provides study specific informed consent prior to study entry.
Documented history and physical exam within 90 days prior to registration.
ECOG PS 0, 1, or 2 within 90 days prior to registration
You may not be if
Non malignant systemic disease that would preclude the patient from receiving study treatment or would prevent required follow up.
Prior invasive non study malignancy unless disease free for ≥ 3 years
* Non melanoma skin cancer, low risk prostate cancer, well differentiated thyroid cancers, in situ carcinomas of the oral cavity, cervix, and other organs, and tumors that are not thought to impact the life expectancy of the patient are permissible.
History of active connective tissue disorder (i.e., systemic lupus erythematosus, scleroderma), dermatomyositis, xeroderma pigmentosum
Clareo Health | Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
